FORTE BIOSCIENCES INC FBRX 深 滬
等待開盤 08-27 09:30:00 美东时间
10.995
-0.320
-2.83%
華盛通- 最 高11.992
- 今 開11.07
- 成交量 5.83万股
- 最 低 10.92
- 昨 收 11.315
- 總市值 1.34亿
- 52周最高 28.68
- 市盈率 靜 --
- 換手率 0.48%
- 52周最低 4.11
- 委 比 -72.15%
- 總股本 1221.38万
- 歷史最高 6732.375
- 量 比 1.32
- 振 幅 9.47%
- 歷史最低 4.90
- 每 手 1
- 風險率 4.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Chardan Capital Maintains Buy on Forte Biosciences, Maintains $61 Price Target
Chardan Capital analyst Daniil Gataulin maintains Forte Biosciences (NASDAQ:FBRX) with a Buy and maintains $61 price target.
08-15 20:11
Forte Biosciences Announces Public Offering of Shares
Forte Biosciences ( ($FBRX) ) just unveiled an update. On June 24, 2025, Forte ...
06-26 05:19
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Plus Therapeutics (NASDAQ:PSTV) stock increased by 66.2% to $0.31 duri...
06-26 01:06
美股大行评级 | 潜在涨幅390.8%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
多家机构首予Amrize买入评级，目标价53~62美元；HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级>>
06-25 08:39
Forte Biosciences launches public offering
Forte Biosciences (NASDAQ:FBRX) has initiated an underwritten public offering of common stock and pre-funded warrants. Certain investors may receive pre-funded warrants instead of common stock. Underw...
06-25 04:16
Chardan Capital Maintains Buy on Forte Biosciences, Maintains $61 Price Target
Chardan Capital analyst Daniil Gataulin maintains Forte Biosciences (NASDAQ:FBRX) with a Buy and maintains $61 price target.
06-24 20:00
Forte Biosciences Reports Results in Celiac Disease Trial, Paving Way for Phase 2 in 2026
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced positive data from a Phase 1b trial in celiac
06-23 19:20
Forte Biosciences Elects New Directors at Annual Meeting
Forte Biosciences ( ($FBRX) ) has provided an update. On May 29, 2025, Forte Bi...
05-30 20:58
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) shares rose 60.0% to $0.64 during Tuesday's regul...
05-28 01:05
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Shares of Novavax, Inc (NASDAQ:NVAX) rose sharply in today's pre-market after t...
05-19 18:34
